Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

Author:

Mahomed Sharana,Garrett Nigel,Capparelli Edmund V,Osman Farzana,Mkhize Nonhlanhla N,Harkoo Ishana,Gengiah Tanuja N,Mansoor Leila E,Baxter Cheryl,Archary Derseree,Yende-Zuma Nonhlanhla,Samsunder Natasha,Carlton Kevin,Narpala Sandeep,McDermott Adrian B,Doria-Rose Nicole A,Moore Penny L,Morris Lynn,Abdool Karim Quarraisha,Mascola John R,Abdool Karim Salim S

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference30 articles.

1. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact,2021

2. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study;de Oliveira;Lancet HIV,2017

3. A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV;Bares;Curr Opin HIV AIDS,2022

4. Clinical trials of broadly neutralizing monoclonal antibodies for HIV prevention: a review;Mahomed;J Infect Dis,2021

5. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape;Moore;Nat Med,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3